AIM
NDRM

Acrospire Investment Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Acrospire Investment Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-237
Closed -$4K – 2374
2016
Q2 		$4K Sell
237
-1,300
-85% -$21.9K ﹤0.01% 1904
2016
Q1 		$22K Buy
+1,537
New +$20.8K 0.02% 1507

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Acrospire Investment Management's NDRM Position: Q3 2016 in Review

Acrospire Investment Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2016, closing a stake of 237 shares — an estimated $4K sold.

Acrospire Investment Management first reported a position in NDRM in Q1 2016 and held it in 2 quarters. The position peaked at $22K in Q1 2016. 50 funds tracked by Wall St. Rank hold NDRM as of Q3 2016.

  • Acrospire Investment Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 237 NeuroDerm Ltd. Ordinary Shares shares in Q3 2016, an estimated $4K.
  • Acrospire Investment Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's NeuroDerm Ltd. Ordinary Shares position peaked at $22K in Q1 2016.
  • 50 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.